A Single-Dose,ComparativeBioavailability Study ofTwo Formulations ofErlotinib150mgTabletsunderFastingConditions

Condition:   Lung Cancer Interventions:   Drug: Erlotinib HCl 150 mg;   Drug: Tarceva® Sponsor:   Quadras Scientific Solutions Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials